Wellcome Trust Sanger Institure – Genome Research Limited
![]() | Wellcome Trust Sanger Institute, Genome Research Limited Genome Research Limited CB10 1SA HINXTON United Kingdom www.sanger.ac.uk |
![]() | principal investigator Tel.: +44 122 349 47 57 Tel.2: +44 122 349 47 39 |
Michael Stratton (MD, PhD) is Director of the Wellcome Trust Sanger Institute. He was leader of the group that mapped and identified the high risk breast cancer susceptibility gene, BRCA2. His research interests are in the genetics of cancer. |